Drug monitoring Flashcards
what are risk factors for myopathy in those on statin therapy
RFs: personal/FHx, muscular disorders, hx of muscular toxicity, high alcohol, renal impairment, hypothyroidism, elderly
what to measure for statin myopathy in those with risk factors
CK
what to measure for statin myopathy in those with NO risk factors
ALT
statin monitoring
Check LFTs at 3 and 12m
When to stop taking a statin
stop if taking a macrolide
+ caution in CYP inducers (ZAG DEVICES)
when is a statin CI
Active liver disease, ALT/AST <3x normal
does phenytoin need monitoring
NO (only check if adjusting dose, suspected toxicity, suspected non-adherence)
ciclosporin monitoring
trough levels immediately before dose
lithium monitoring
sample 12h after last dose
- monitor weekly after 1st dose/change until stable
- and every 3m
lithium therapeutic range + toxic effects
therapeutic range 0.4-0.8
toxic effects >1.5
low Na+ –> higher lithium toxicity risk
what to use as anti-hypertensive with lithium
CCBs (amlodipine)
NOT ACEi, thiazides, loops
NO NSAIDs
methotrexate monitoring
FBC, U+E, LFTs every 2-2wks until stable
then FBC, U+E, LFTs every 2-3 months
usu taken ONCE A WEEK
when should a statin be taken
ONCE AT NIGHT
methotrexate important to tell pts
REPORT SORE THROATS/INFECTIONS
methotrexate imp CI
abnormal LFTs
how often should methotrexate be taken
Once a week
Antipsychotics Monitoring at 0m (5 things)
- ECG (if RF for CVD)
- Prolactin
- Lipids
- Weight
- BMs
Antipsychotics Monitoring at 1m
- Weight
5. BMs